Fitgurú on MSN
Are you accidentally destroying your muscle when you diet after 50? The silent longevity trap men must avoid
Slashing calories without lifting heavy resistance strips away vital lean tissue, sabotaging your metabolism and robbing you ...
New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss ...
Let’s get one thing straight: Muscle is muscle. Despite what many fitness influencers may have you believe, there’s no such thing as "lean muscle" or "bulk muscle." It’s all made from the same stuff.
Don't skip these non-negotiables ...
Men generally need about 56 grams of protein per day with a sedentary lifestyle. Individual needs may vary based on factors such as activity level, weight, age, and illness. Protein intake should be ...
GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...
Let’s get one thing straight: muscle is muscle. Despite what many fitness influencers may have you believe, there is no such thing as "lean muscle" versus "bulk muscle" in the biological sense.
A new study from Western New England University (WNE) has revealed that long-term grape consumption significantly impacts muscle health, with notable benefits for both men and women. The research, ...
A large portion of people who work out regularly aspire to build definition, strength, and a physique that appears athletic, but does not make them look like a bodybuilder. Active adults who are ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Some patient populations may be at higher risk for lean ...
SAN FRANCISCO--(BUSINESS WIRE)--Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from its ongoing open-label Phase 1/2 ...
Single-Dose EPI-321 Demonstrated a Positive Safety Profile and Increased Lean Muscle Volume Across the First Three Evaluable Patients at Six Months EPI-321 is the First Investigational Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results